saj Archives - AMERSA

SAj Flashback: Addiction Medicine in the Time of COVID-19: An Overview of the 2020 Joint Scientific Annual Conference of the International Society of Addiction Medicine and Canadian Society of Addiction Medicine

Oct 8, 2022 by AMERSA

This editorial looks back at the events of the International Society of Addiction Medicine and Canadian Society of Addiction Medicine 2020 conference, the third to be held in conjunction with the Canadian Society of Addiction Medicine (CSAM) and the first virtual conference. The conference was attended by over 800 participants and covered a wide range of topics, including addiction medicine during the COVID-19 pandemic. Despite the challenges of not being able to meet physically in Victoria, British Columbia as had been planned, the virtual event provided an opportunity to share current information in order to help advance prevention, treatment, policy and public health efforts relating to addressing addictions and helping those impacted by these often devastating conditions.

This editorial comes from authors Marc N. Potenza, MD, PhD and Nady el-Guebaly, MD, DPsych, DPH and can be found in SAj Volume 43, Issue 3 or online.

Substance Abuse journal Volume 40 | Issue 2

Nov 22, 2019 by AMERSA

The Authors’ Own Words for Volume 40, Issue 2 have come to end. We always enjoy reading what the authors have to say about their work and we hope that you do too!

We think that this was a great issue of SAj. If you haven’t read it yet, you still can! Substance Abuse journal, Vol. 40, Iss. 2

The most viewed piece of work in this issue was:

Demystifying buprenorphine misuse: Has fear of diversion gotten in the way of addressing the opioid crisis?

Molly Doernberg BA; Noa Krawczyk BA; Deborah Agus JD; & Michael Fingerhood MD

with 361 views (and counting!)

Substance Abuse journal Volume 40 | Issue 1

Nov 13, 2019 by AMERSA

The Authors’ Own Words for Volume 40, Issue 1 have come to end. We really enjoyed getting the chance to read some insights from some of the authors themselves.

You can read the entire issue now! Substance Abuse journal, Vol. 40, Iss. 1

It was a lot of fun revisiting this issue. This issue was packed with some of the best editorials, reviews, commentaries, reports, and research that our field has to offer!

The most viewed pieces of work in this issue were:

1. Opioid discontinuation as an institutional mandate: Questions and answers on why we wrote to the Centers for Disease Control and Prevention

Stefan G. Kertesz MSc, MD, Sally L. Satel MD, James DeMicco PharmD, Richard C. Dart MD, PhD & Daniel P. Alford MD, MPH

with 2326 views (and counting!)

2. Understanding the implications of the “vaping epidemic” among adolescents and young adults: A call for action

Nicholas Chadi MD, Scott E. Hadland MD, MPH, MS & Sion K. Harris PhD

with 1495 views (and counting!)

The Authors’ Own Words: Interest in prescribing buprenorphine among resident and attending physicians at an urban teaching clinic.

Nov 8, 2019 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Interest in prescribing buprenorphine among resident and attending physicians at an urban teaching clinic

Jocelyn R. James, MD; Leah M. Gordon, MD, MPH; Jared W. Klein, MD, MPH; Joseph O. Merrill , MD, MPH; Judith I. Tsui , MD, MPH

Substance Abuse Vol. 40, Iss. 1, 2019

“This academic medical center based study on attitudes toward buprenorphine maintenance treatment for opioid use disorder suggests that internal medicine physicians, especially those who are younger and who believe that buprenorphine is effective, have high interest in becoming waivered to prescribe buprenorphine. Integrating buprenorphine education, training, and waiver opportunities into residency programs may create a pipeline of buprenorphine providers and thereby expand access to effective opioid use disorder treatment.”